Carson Wealth (CWM LLC)
CTNM

Carson Wealth (CWM LLC)’s Contineum Therapeutics CTNM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Sell
1,145
-35
-3% -$469 ﹤0.01% 4588
2025
Q4 		$13K Sell
1,180
-69
-6% -$787 ﹤0.01% 4437
2025
Q3 		$15K Sell
1,249
-1,495
-54% -$12.1K ﹤0.01% 4289
2025
Q2 		$11K Buy
2,744
+2,329
+561% +$10.1K ﹤0.01% 4267
2025
Q1 		$3K Buy
415
+401
+2,864% +$3.65K ﹤0.01% 4707
2024
Q4 		$0 Sell
14
-14
-50% -$222 ﹤0.01% 5213
2024
Q3 		$1K Buy
+28
New +$537 ﹤0.01% 4759

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Carson Wealth (CWM LLC)'s CTNM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Contineum Therapeutics (CTNM) stake by 3% in Q1 2026, selling an estimated $469 and leaving 1,145 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #4588.

Carson Wealth (CWM LLC) first reported a position in CTNM in Q3 2024 and has held it in 7 quarters since. The position peaked at $15K in Q3 2025. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,145 shares of Contineum Therapeutics worth $15K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 35 Contineum Therapeutics shares in Q1 2026, an estimated $469.
  • Contineum Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4588 holding.
  • Carson Wealth (CWM LLC) first reported a position in Contineum Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s Contineum Therapeutics position peaked at $15K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.